Rapid efficacy of the highly selective α1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: Pooled results of 2 phase 3 studies

Journal of Urology

Volumn 189, Issue 1 SUPPL, 2013, Pages

  Marks, Leonard S ^a   Gittelman, Marc C ^b   Hill, Lawrence A ^c   Volinn, Weining ^c   Hoel, Gary ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b South Florida Medical Research   (United States)

^c Watson Laboratories   (United States)

Author keywords

KMD 3213; prostatic hyperplasia; signs and symptoms

Indexed keywords

PLACEBO; SILODOSIN;

AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GROUPS BY AGE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE OBSTRUCTION; ORTHOSTATIC HYPOTENSION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; RETROGRADE EJACULATION; RHINOPHARYNGITIS; TREATMENT OUTCOME; URINE FLOW RATE;

EID: 84870925729     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.11.020     Document Type: Article

References (21)

1. J.T. Wei, E.A. Calhoun, S.J. Jacobsen Benign prostatic hyperplasia M.S. Litwin, C.S. Saigal, Urologic Diseases in America 2007 National Kidney and Urologic Diseases Information Clearinghouse Bethesda, MD 43 67 NIH publication 07-5512 http://kidney.niddk.nih.gov/statistics/uda/ (updated February 2007). Accessed August 28, 2008
2. H. Lepor Pathophysiology of lower urinary tract symptoms in the aging male population Rev Urol 7 2005 S3
3. 1- adrenoceptor antagonists in the lower urinary tract and central nervous system Nat Clin Pract Urol 4 2007 368
4. 1-Adrenoceptor subtypes and lower urinary tract symptoms Int J Urol 15 2008 193
5. 1c-)adrenoceptor subtype Br J Pharmacol 115 1995 781
6. 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery Br J Pharmacol 113 1994 723
7. 1-adrenoreceptor antagonist, in human prostate and vasculature J Urol 164 2000 578
8. C. Chapple, K.E. Andersson Tamsulosin: an overview World J Urol 19 2002 397
9. C. de Mey, M.C. Michel, J. McEwen, T. Moreland A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing Eur Urol 33 1998 481
10. 1- adrenoceptors and native tissues Mol Pharmacol 48 1995 250
11. 1A-adrenoceptor subtype selectivity of KMD-3213 in rat tissues J Pharmacol Exp Ther 296 2001 160
12. 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta Eur J Pharmacol 315 1996 73
13. 1a-adrenoceptor antagonist, tested in a novel rat model J Pharmacol Exp Ther 291 1999 81
14. Minipress (prazocin hydrochloride) prescribing information MedWatch Web site http://www.fda.gov/medwatch/safety/2001/jun01.htm (updated June 2001). Accessed August 28, 2008
15. 1A- adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men BJU Int 98 2006 1019
16. K. Höfner, H. Claes, T.M. De Reijke, B. Folkestad, M.J. Speakman Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction Eur Urol 36 1999 335
17. 1-adrenoceptor antagonists on male sexual function Drugs 66 2006 287
18. C.G. Roehrborn, P. Van Kerrebroeck, J. Nordling Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies BJU Int 92 2003 257
19. H. Lepor Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia Tamsulosin Investigator Group Urology 51 1998 892
20. S. Madersbacher, M. Marszalek, J. Lackner, P. Berger, G. Schatzl The long-term outcome of medical therapy for BPH Eur Urol 51 2007 1522
21. American Urological Association Clinical Guidelines: Management of BPH ('03/Updated '06) Chapter 3 with Appendix: results of the treatment outcomes analyses http://www.auanet.org/content/guidelines-and-quality-care/clinical- guidelines.cfm?sub=bph Accessed December 3, 2008